USPTO Examiner BLANCO JAVIER G - Art Unit 3774

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18826063Joint Implants With Bone Interface ConnectorsSeptember 2024January 2025Allow501YesNo
18645617MULTICOMPONENT ARTICULAR SURFACE IMPLANTApril 2024December 2024Allow700NoNo
18634703DEVICE AND METHOD WITH REDUCED PACEMAKER RATE IN HEART VALVE REPLACEMENTApril 2024April 2025Allow1220YesNo
18630351JOINT IMPLANT WITH CONSTANT AND CONTINUOUS RELEASE OF THERAPEUTIC AGENTApril 2024June 2025Abandon1410NoNo
18608361INTRAOCULAR LENS HAVING CLOSED-LOOP HAPTIC STRUCTURESMarch 2024April 2025Abandon1310NoNo
18587687INTRAOCULAR LENSES HAVING ZONE-BY-ZONE STEP HEIGHT CONTROLFebruary 2024December 2024Allow900YesNo
18587766SUSPENDED SLEEVE ASSEMBLY COMPRISING A COMPRESSION SLEEVE AND A SUSPENSION STANDFebruary 2024April 2025Abandon1410NoNo
18436900Bioactive Soft Tissue Implant And Methods Of Manufacture And Use ThereofFebruary 2024July 2024Allow501YesNo
18407726OPHTHALMIC LENSES HAVING AN EXTENDED DEPTH OF FOCUS FOR IMPROVING INTERMEDIATE VISIONJanuary 2024April 2025Allow1610NoNo
18393551OPHTHALMIC DEVICES, SYSTEM AND METHODS THAT IMPROVE PERIPHERAL VISIONDecember 2023January 2025Allow1301YesNo
18389701MULTI-REGION REFRACTIVE LENSES FOR VISION TREATMENTDecember 2023December 2024Allow1101YesNo
18544133ACHROMATIC LENSES AND LENSES HAVING DIFFRACTIVE PROFILES WITH IRREGULAR WIDTH FOR VISION TREATMENTDecember 2023June 2025Allow1810YesNo
18542499ACHROMATIC LENSES WITH ZONE ORDER MIXING FOR VISION TREATMENTDecember 2023November 2024Allow1101YesNo
18534691PARTITION DESIGN AND MOLDING METHOD FOR ACETABULAR CUP PROSTHESIS WITH POROUS SURFACEDecember 2023June 2024Allow600YesNo
18521847ACETABULAR RECONSTRUCTION PROSTHESIS WITH PILING-CUP SYSTEMNovember 2023March 2024Allow300YesNo
18519178GLENOID IMPLANT ANCHOR POSTNovember 2023August 2024Allow900YesNo
18514281Fixation Devices And Prostheses For Soft Tissue Connection To The SameNovember 2023May 2025Allow1811YesNo
18504635SYSTEMS, METHODS, AND DEVICES FOR LATERAL AND POSTERIOR SACROILIAC JOINT FUSIONNovember 2023January 2025Allow1421YesNo
18504370Lenticules for Intrastromal Corneal ImplantationNovember 2023February 2025Allow1520NoNo
18491736INTRAOCULAR LENSES THAT IMPROVE PERIPHERAL VISIONOctober 2023September 2024Allow1100YesNo
18489891SYSTEMS AND METHODS FOR KNEE ARTHROPLASTYOctober 2023June 2024Allow800YesNo
18485546INTRAOCULAR DRUG DELIVERY PLATFORMOctober 2023July 2024Allow1000YesNo
18370945Femoral Component For Bone ConservationSeptember 2023January 2025Allow1611YesNo
18470936INTRAOCULAR PSEUDOPHAKIC CONTACT LENS (IOPCL)-BASED TELESCOPIC APPROACH FOR TREATING AGE-RELATED MACULAR DEGENERATION (AMD) OR OTHER EYE DISORDERSSeptember 2023December 2024Allow1410NoNo
18455371STABLE IOL BASE DESIGN TO SUPPORT SECOND OPTICAugust 2023September 2024Allow1300YesNo
18452633Devices for Reconstruction of a Lens Capsule after Cataract SurgeryAugust 2023April 2025Allow2001NoNo
18366376METHOD AND DEVICE FOR TREATING EYE DISEASEAugust 2023January 2025Allow1701YesNo
18230908IMPLANT AND IMPLANT SYSTEMAugust 2023June 2024Allow1000YesNo
18359744STAPHYLOMA SUPPORTING DEVICE AND METHOD FOR MODIFYING THE AXIAL LENGTH AND CURVATURE OF AN EYEJuly 2023May 2024Allow1000NoNo
18357441FULL DEPTH OF FOCUS INTRAOCULAR LENSJuly 2023November 2024Allow1610YesNo
18349805METHODS FOR LESS INVASIVE GLENOID REPLACEMENTJuly 2023May 2024Allow1000YesNo
18339150SACROILIAC JOINT STABILIZATION SYSTEMJune 2023November 2024Allow1731YesNo
18325280IN-SITU ADJUSTABLE INTRAOCULAR LENSMay 2023August 2024Allow1501YesNo
18324951SYNTHETIC HYDROGEL COMPOSITEMay 2023April 2024Allow1100YesNo
18322489PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODSMay 2023April 2024Allow1100YesNo
18321083HARD-TISSUE IMPLANT COMPRISING A BULK IMPLANT, A FACE, PILLARS, SLOTS, AND AT LEAST ONE SUPPORT MEMBERMay 2023April 2024Allow1100YesNo
18141636WRIST ARTHROPLASTY SYSTEM AND METHODMay 2023December 2024Allow2000NoNo
18307147ELECTROWETTING OPHTHALMIC DEVICES INCLUDING AN ELASTIC ELECTRODEApril 2023August 2024Allow1510YesNo
18306347HEAT TUNABLE INTRAOCULAR LENSApril 2023May 2025Allow2521NoNo
18302298ADJUSTABLE INTRAOCULAR LENSES AND METHODS OF POST-OPERATIVELY ADJUSTING INTRAOCULAR LENSESApril 2023August 2024Allow1601YesNo
18298595MODULAR KNEE AUGMENT CONESApril 2023April 2024Allow1200YesNo
18295912INTRAOCULAR LENS INSERTION DEVICEApril 2023November 2023Allow702YesNo
18127078ADJUSTABLE TIBIAL TRIAL INSTRUMENT AND ORTHOPAEDIC SURGICAL METHOD OF USING THE SAMEMarch 2023March 2024Allow1200YesNo
18126301PERCUTANEOUS HEART VALVE PROSTHESISMarch 2023March 2024Allow1200YesNo
18124425INTRAOCULAR LENSMarch 2023February 2024Allow1101YesNo
18186826PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODSMarch 2023March 2024Allow1100YesNo
18171343ACHROMATIC LENSES FOR VISION TREATMENTFebruary 2023June 2024Allow1601YesNo
18106708BONE IMPLANT HOLDING AND SHAPING TRAYFebruary 2023March 2024Allow1400YesNo
18095981SACROILIAC JOINT STABILIZATION SYSTEMJanuary 2023July 2023Allow601YesNo
18067284INTRAOCULAR LENS HAVING INPUT AND OUTPUT ELECTRONICSDecember 2022February 2024Allow1400YesNo
18066872THREADED IMPLANTS AND METHODS OF USE ACROSS BONE SEGMENTSDecember 2022June 2025Allow3020YesNo
18064235INTRAOCULAR LENS THAT IMPROVES OVERALL VISION WHERE THERE IS A LOCAL LOSS OF RETINAL FUNCTIONDecember 2022April 2025Allow2830YesNo
18072445HYBRID ACCOMODATING INTRA-OCULAR LENS AND METHOD OF USE THEREOFNovember 2022June 2025Allow3110NoNo
18070737SYSTEMS AND METHODS FOR PREPARING CORNEAL TISSUE FOR IMPLANTNovember 2022February 2024Allow1400YesNo
18058150METHODS FOR LESS INVASIVE GLENOID REPLACEMENTNovember 2022February 2023Allow200YesNo
17989763ARTIFICIAL DISK WITH SENSORSNovember 2022January 2025Allow2620YesNo
17987047REPAIR OF SHOULDER-JOINT LESIONSNovember 2022February 2023Allow301YesNo
18052853DIFFRACTIVE INTRAOCULAR LENSES FOR EXTENDED RANGE OF VISIONNovember 2022March 2025Allow2911NoNo
17975872CORNEAL IMPLANTOctober 2022January 2024Allow1500YesNo
17975851CORNEAL IMPLANTOctober 2022August 2024Allow2220NoNo
17973964IMPLANT FOR REMOVABLE PROSTHETIC NAILOctober 2022February 2024Allow1500YesNo
17966663PERCUTANEOUS HEART VALVE PROSTHESISOctober 2022February 2023Allow410YesNo
18045622MINIMALLY INVASIVE AB INTERNO TRIPLE SURGERY FOR OPEN-ANGLE GLAUCOMAOctober 2022August 2023Allow1010YesNo
17937076OPHTHALMIC IMPLANTS FOR CORRECTING VISION WITH A TUNABLE OPTIC, AND METHODS OF MANUFACTURE AND USESeptember 2022January 2025Allow2801YesNo
17952672COMPOSITE JOINT IMPLANTSeptember 2022December 2024Abandon2711NoNo
17943525ORTHOPAEDIC KNEE IMPLANT SYSTEM WITH CONTROLLED STIFFNESSSeptember 2022January 2024Allow1600YesNo
17942892Meniscus Prosthetic Devices with Anti-Migration or Radiopaque FeaturesSeptember 2022December 2023Allow1500YesNo
17929473AUGMENTATION DEVICE, AUGMENTATION SYSTEM, AND IMPLANTATION METHODSeptember 2022February 2025Allow3011YesNo
17895585NON-PATIENT-SPECIFIC CRANIOFACIAL IMPLANTS FOR CORRECTING AND/OR PREVENTING TEMPORAL OR PTERIONAL DEFORMITIESAugust 2022November 2023Allow1500YesNo
17878196METHODS AND APPARATUSES FOR ATTACHMENT OF POROUS COATINGS TO IMPLANTS AND PRODUCTS THEREOFAugust 2022December 2023Allow1600YesNo
17759249STAPHYLOMA SUPPORTING DEVICE AND METHOD FOR MODIFYING THE AXIAL LENGTH AND CURVATURE OF AN EYEJuly 2022April 2023Allow901YesNo
17868127PASSIVELY-COUPLED EYE IMPLANTJuly 2022July 2024Allow2400YesNo
17851373ORTHOPAEDIC KNEE PROSTHESIS HAVING CONTROLLED CONDYLAR CURVATUREJune 2022January 2024Allow1800YesNo
17849031BONE GRAFT SYSTEMJune 2022June 2024Allow2300YesNo
17845881SYNTHETIC HYDROGEL COMPOSITEJune 2022December 2022Allow601YesNo
17807548PROTECTIVE LENS HOLDERJune 2022January 2024Allow1910YesNo
17839407EXCHANGEABLE OPTICS AND THERAPEUTICSJune 2022January 2024Allow1900YesNo
17784049EYE IMPLANT FOR AN ACCOMMODATIVE INTRAOCULAR LENSJune 2022April 2023Allow1002YesNo
17829726INTRAOCULAR LENSES WITH SHAPE-CHANGING OPTICS AND STABILIZING PROPERTIESJune 2022December 2022Allow610YesNo
17804120OPHTHALMIC LENSES FOR BALANCING COMA ABERRATIONSMay 2022May 2024Allow2300YesNo
17752352ORTHOPAEDIC FEMORAL COMPONENT HAVING CONTROLLED CONDYLAR CURVATUREMay 2022June 2024Allow2510YesNo
17751555INTRAOCULAR PSEUDOPHAKIC CONTACT LENS WITH MECHANISM FOR SECURING BY ANTERIOR LEAFLET OF CAPSULAR WALL AND RELATED SYSTEM AND METHODMay 2022June 2025Allow3700YesNo
17750774LATERALIZED DUAL-MOBILITY ASSEMBLYMay 2022November 2023Allow1700YesNo
17663748INTRAOCULAR LENSES HAVING ZONE-BY-ZONE STEP HEIGHT CONTROLMay 2022November 2023Allow1800YesNo
17662599INTRAOCULAR IMPLANT WITH REMOVABLE OPTICMay 2022May 2024Abandon2410NoNo
17739715PROSTHETIC STEM FOR A PROSTHETIC IMPLANTMay 2022January 2024Allow2001YesNo
17773743TIBIAL PROSTHESIS AND KNEE PROSTHESISMay 2022April 2025Allow3600NoNo
17728773SUSPENDED SLEEVE ASSEMBLY COMPRISING A COMPRESSION SLEEVE AND A SUSPENSION STANDApril 2022October 2023Allow1800YesNo
17725046Bioactive Soft Tissue Implant And Methods Of Manufacture And Use ThereofApril 2022August 2024Allow2801YesNo
17659588GLENOID IMPLANT ANCHOR POSTApril 2022September 2023Allow1700YesNo
17657522SYSTEMS AND METHODS FOR CONTROLLED FACET REPOSITIONING IN THE CALCANEUSMarch 2022June 2025Allow3901YesNo
17707188Cartilage Measurement Device and Method of UseMarch 2022October 2023Allow1901YesNo
17763923INTERSPINOUS STABILIZATION DEVICEMarch 2022December 2024Allow3220YesNo
17761751ENDOPROSTHESIS AND A METHOD OF PRODUCING AN ENDOPROSTHESISMarch 2022May 2025Allow3801YesNo
17761441INTRAOCULAR LENSMarch 2022January 2025Abandon3401NoNo
17693283Dome Toe Resurfacing SystemMarch 2022May 2023Allow1400YesNo
17640214MEMBRANE BODY FOR TUBULAR TREATMENT DEVICE AND TUBULAR TREATMENT DEVICEMarch 2022March 2025Allow3610YesNo
17677579LINER FOR PROSTHETIC AND ORTHOPEDIC SYSTEMSFebruary 2022December 2023Allow2201YesNo
17650192PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODSFebruary 2022May 2023Allow1500YesNo
17587422INTRAOCULAR LENS INCLUDING SILICONE OILJanuary 2022May 2022Allow410YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BLANCO, JAVIER G.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
17
Examiner Affirmed
12
(70.6%)
Examiner Reversed
5
(29.4%)
Reversal Percentile
45.1%
Lower than average

What This Means

With a 29.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
47
Allowed After Appeal Filing
8
(17.0%)
Not Allowed After Appeal Filing
39
(83.0%)
Filing Benefit Percentile
18.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 17.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BLANCO, JAVIER G - Prosecution Strategy Guide

Executive Summary

Examiner BLANCO, JAVIER G works in Art Unit 3774 and has examined 1,087 patent applications in our dataset. With an allowance rate of 81.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 26 months.

Allowance Patterns

Examiner BLANCO, JAVIER G's allowance rate of 81.3% places them in the 46% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BLANCO, JAVIER G receive 1.27 office actions before reaching final disposition. This places the examiner in the 24% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BLANCO, JAVIER G is 26 months. This places the examiner in the 64% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +59.4% benefit to allowance rate for applications examined by BLANCO, JAVIER G. This interview benefit is in the 97% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 29.8% of applications are subsequently allowed. This success rate is in the 49% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 14.2% of cases where such amendments are filed. This entry rate is in the 9% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 60.5% of appeals filed. This is in the 32% percentile among all examiners. Of these withdrawals, 38.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 40.9% are granted (fully or in part). This grant rate is in the 41% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 9.5% of allowed cases (in the 95% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.2% of allowed cases (in the 45% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.